Older patients Older patients have a high prevalence of other obstructive lung disease (eg, COPD), so it is important to determine the magnitude of the reversible component of airflow obstruction (eg, by a 2 - to 3-week trial of inhaled corticosteroids or pulmonary function testing with bronchodilator challenge).